RAC 2.74% $1.50 race oncology ltd

RAC media coverage, page-183

  1. 2,289 Posts.
    lightbulb Created with Sketch. 2798
    I also perceive that there is a general apathy and oversight of Australian biomedical companies by the large multinational pharmaceutical companies. I hope, no expect, that Race Oncology will be the catalyst for change, and a significant global buyout will represent the start of a golden age for the sector in Aust/NZ.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.